• Something wrong with this record ?

Hyperbilirubinemia Protects against Aging-Associated Inflammation and Metabolic Deterioration

J. Zelenka, A. Dvořák, L. Alán, M. Zadinová, M. Haluzík, L. Vítek,

. 2016 ; 2016 (-) : 6190609. [pub] 20160731

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc17013580

Mild constitutive hyperbilirubinemia is associated with a reduced risk of cardiovascular diseases, diabetes, and cancer. Since these pathologies are associated with aging, inflammation, and oxidative stress, we investigated whether hyperbilirubinemia interferes with ROS homeostasis in cell cultures and with inflammation, senescence, and mitochondrial dysfunction in aged rats. Human embryonic kidney cells and rat primary fibroblasts showed a dose-dependent decrease in the ratio of oxidized/reduced glutathione, intracellular H2O2 levels, and mitochondrial ROS production, with increasing bilirubin concentrations in the culture media. Compared to their normobilirubinemic siblings, aged hyperbilirubinemic Gunn rats showed significantly smaller amounts of visceral fat, better glucose tolerance, and decreased serum levels of proinflammatory cytokines TNFα, IL-1β, and IL-18. Simultaneously, livers from Gunn rats showed decreased expression of senescence markers and cell cycle inhibitors p21 and p16. Mitochondria from aged Gunn rats showed higher respiration and lower H2O2 production compared to controls. In conclusion, we demonstrated that mildly elevated serum bilirubin is generally associated with attenuation of oxidative stress and with better anthropometric parameters, decreased inflammatory status, increased glucose tolerance, fewer signs of cellular senescence, and enhanced mitochondrial function in aged rats.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013580
003      
CZ-PrNML
005      
20170418103344.0
007      
ta
008      
170413s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2016/6190609 $2 doi
035    __
$a (PubMed)27547293
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Zelenka, Jaroslav $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague, Czech Republic.
245    10
$a Hyperbilirubinemia Protects against Aging-Associated Inflammation and Metabolic Deterioration / $c J. Zelenka, A. Dvořák, L. Alán, M. Zadinová, M. Haluzík, L. Vítek,
520    9_
$a Mild constitutive hyperbilirubinemia is associated with a reduced risk of cardiovascular diseases, diabetes, and cancer. Since these pathologies are associated with aging, inflammation, and oxidative stress, we investigated whether hyperbilirubinemia interferes with ROS homeostasis in cell cultures and with inflammation, senescence, and mitochondrial dysfunction in aged rats. Human embryonic kidney cells and rat primary fibroblasts showed a dose-dependent decrease in the ratio of oxidized/reduced glutathione, intracellular H2O2 levels, and mitochondrial ROS production, with increasing bilirubin concentrations in the culture media. Compared to their normobilirubinemic siblings, aged hyperbilirubinemic Gunn rats showed significantly smaller amounts of visceral fat, better glucose tolerance, and decreased serum levels of proinflammatory cytokines TNFα, IL-1β, and IL-18. Simultaneously, livers from Gunn rats showed decreased expression of senescence markers and cell cycle inhibitors p21 and p16. Mitochondria from aged Gunn rats showed higher respiration and lower H2O2 production compared to controls. In conclusion, we demonstrated that mildly elevated serum bilirubin is generally associated with attenuation of oxidative stress and with better anthropometric parameters, decreased inflammatory status, increased glucose tolerance, fewer signs of cellular senescence, and enhanced mitochondrial function in aged rats.
650    _2
$a stárnutí $x patologie $7 D000375
650    _2
$a zvířata $7 D000818
650    _2
$a bilirubin $x krev $7 D001663
650    _2
$a kultivované buňky $7 D002478
650    _2
$a fibroblasty $x metabolismus $x patologie $7 D005347
650    _2
$a hyperbilirubinemie $x krev $x patologie $7 D006932
650    _2
$a zánět $x komplikace $x patologie $7 D007249
650    _2
$a intracelulární prostor $x metabolismus $7 D042541
650    _2
$a metabolické nemoci $x komplikace $x patologie $7 D008659
650    _2
$a mitochondrie $x metabolismus $7 D008928
650    _2
$a potkani Gunn $7 D011911
650    _2
$a reaktivní formy kyslíku $x metabolismus $7 D017382
655    _2
$a časopisecké články $7 D016428
700    1_
$a Dvořák, Aleš $u Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, 142 20 Prague, Czech Republic; Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University in Prague, Na Bojišti 3, 128 08 Prague, Czech Republic.
700    1_
$a Alán, Lukáš $u Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, 142 20 Prague, Czech Republic. $7 gn_A_00003279
700    1_
$a Zadinová, Marie $u Institute of Biophysics, 1st Faculty of Medicine, Charles University in Prague, Salmovská 1, 128 08 Prague, Czech Republic.
700    1_
$a Haluzík, Martin $u Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University in Prague, Na Bojišti 3, 128 08 Prague, Czech Republic; Institute of Endocrinology, Národní 8, 116 94 Prague, Czech Republic.
700    1_
$a Vítek, Libor $u Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University in Prague, Na Bojišti 3, 128 08 Prague, Czech Republic; 4th Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague, U Nemocnice 2, 128 08 Prague, Czech Republic.
773    0_
$w MED00180520 $t Oxidative medicine and cellular longevity $x 1942-0994 $g Roč. 2016, č. - (2016), s. 6190609
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27547293 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170418103652 $b ABA008
999    __
$a ok $b bmc $g 1200045 $s 974358
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 2016 $c - $d 6190609 $e 20160731 $i 1942-0994 $m Oxidative medicine and cellular longevity $n Oxid Med Cell Longev $x MED00180520
LZP    __
$a Pubmed-20170413

Find record

Citation metrics

Archiving options